The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations.
 
Priscilla Kaliopi Brastianos
Honoraria - Pfizer
Consulting or Advisory Role - Advise Connect Inspire; Axiom Health; Dantari Pharmaceuticals; ElevateBio; Kazia Therapeutics; Medscape; MPM Capital; Sintetica; Voyager Therapeutics
Research Funding - Kinnate Biopharma (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Katharine Dooley
No Relationships to Disclose
 
Susan Michelle Geyer
No Relationships to Disclose
 
Elizabeth R Gerstner
Consulting or Advisory Role - Array BioPharma (I); Midatech Pharma; MyoKardia (I)
 
Timothy J. Kaufmann
Stock and Other Ownership Interests - SpineThera
 
A. John Iafrate
Consulting or Advisory Role - Kinnate Biopharma; Oncoclinicas Brasil; PAIGE.AI; Repare Therapeutics; SequreDx
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Mohammed M. Milhem
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Mary Roberta Welch
Research Funding - Boston Biomedical; Inovio Pharmaceuticals
Travel, Accommodations, Expenses - Boston Biomedical; Inovio Pharmaceuticals
 
Thomas Joseph Kaley
No Relationships to Disclose
 
Jan Drappatz
Leadership - Elsevier
Stock and Other Ownership Interests - Biogen; Bristol-Myers Squibb; Exelixis; Gilead Sciences; GlaxoSmithKline; Pfizer
Honoraria - Elsevier; UpToDate
Consulting or Advisory Role - Agios; Immunomic Therapeutics; Novocure; Oncorus
Patents, Royalties, Other Intellectual Property - uptodate
 
Amy Chan
Research Funding - Novocure (Inst)
 
Priya Kumthekar
Consulting or Advisory Role - Affinia Therapeutics; Belay Diagnostics; Biocept; BioClinica; Biodexa; BPGbio; EnClear Therapies; IN8bio; Novocure; Plus Therapeutics; SDP Oncology; SERVIER; Telix Pharmaceuticals
Speakers' Bureau - Seagen
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose
 
Roy E. Strowd
Consulting or Advisory Role - Alexion Pharmaceuticals; Monteris Medical; Monteris Medical; Novocure
Research Funding - Alpha Omega Alpha; American Board of Psychiatry and Neurology; Jazz Pharmaceuticals; NIH; Southeastern Brain Tumor Foundation
Patents, Royalties, Other Intellectual Property - Elsevier, book royalties; Lecturio, lecture royalties
Other Relationship - American Academy of Neurology (AAN)
 
Adam Louis Cohen
Employment - INOVA Health System
Research Funding - Acrotech Biopharma (Inst); Berg Pharmaceuticals (Inst); Chimerix (Inst); Novartis (Inst)
 
Kurt A. Jaeckle
Stock and Other Ownership Interests - Entegrion
Research Funding - Boehringer Ingelheim (Inst); Novocure (Inst); Wayshine Biopharma (Inst)
 
Lindsay Robell
No Relationships to Disclose
 
Sandro Santagata
No Relationships to Disclose
 
Frederick G. Barker
No Relationships to Disclose
 
Evanthia Galanis
Consulting or Advisory Role - Boston Scientific (Inst); Karyopharm Therapeutics (Inst); KIYATEC; SERVIER (Inst)
Research Funding - Denovo Biopharma (Inst); MedImmune (Inst); SERVIER (Inst)